| pubmed-article:21456918 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21456918 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21456918 | lifeskim:mentions | umls-concept:C0740345 | lld:lifeskim |
| pubmed-article:21456918 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:21456918 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:21456918 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21456918 | pubmed:dateCreated | 2011-4-4 | lld:pubmed |
| pubmed-article:21456918 | pubmed:abstractText | The authors evaluated the effectiveness of a neoadjuvant therapy (NAT) consisting of combined chemo and radiotherapy followed by complete resection of the residual tumor in patients with nongerminomatous malignant germ cell tumors (NGMGCTs). | lld:pubmed |
| pubmed-article:21456918 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21456918 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21456918 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21456918 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21456918 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21456918 | pubmed:issn | 1933-0715 | lld:pubmed |
| pubmed-article:21456918 | pubmed:author | pubmed-author:UshioYukitaka... | lld:pubmed |
| pubmed-article:21456918 | pubmed:author | pubmed-author:NakamuraHideo... | lld:pubmed |
| pubmed-article:21456918 | pubmed:author | pubmed-author:KochiMasatoM | lld:pubmed |
| pubmed-article:21456918 | pubmed:author | pubmed-author:KuratsuJun-ic... | lld:pubmed |
| pubmed-article:21456918 | pubmed:author | pubmed-author:MakinoKeishiK | lld:pubmed |
| pubmed-article:21456918 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21456918 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:21456918 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21456918 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21456918 | pubmed:pagination | 431-8 | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:meshHeading | pubmed-meshheading:21456918... | lld:pubmed |
| pubmed-article:21456918 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21456918 | pubmed:articleTitle | Evaluation of neoadjuvant therapy in patients with nongerminomatous malignant germ cell tumors. | lld:pubmed |
| pubmed-article:21456918 | pubmed:affiliation | Department of Neurosurgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. hnakamur@fc.kuh.kumamoto-u.ac.jp | lld:pubmed |
| pubmed-article:21456918 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21456918 | pubmed:publicationType | Case Reports | lld:pubmed |
